report
female
patient
rheumatoid arthritis
acute
cytolytic hepatitis
meloxicam
Belgium
meloxicam
nonsteroidal antiinflammatory
selective action
inducible form
cyclooxygenase 2
acute
cytolytic hepatitis
meloxicam
administration
associated with
development
antinuclear antibodies
hypersensitivity
mechanism
meloxicam
liver
toxicity
potential
drug
induce
hepatic damage
